BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7140421)

  • 1. The role of culture media on the fosfomycin sensitivity of six Serratia strains and their resistant mutants.
    Drugeon HB; Courtieu AL
    Chemotherapy; 1982; 28(5):345-50. PubMed ID: 7140421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of fosfomycin activity in Mueller-Hinton media and in tissues.
    Dette GA; Knothe H; Schönenbach B; Plage G
    J Antimicrob Chemother; 1983 Jun; 11(6):517-24. PubMed ID: 6885678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility to fosfomycin of hospital strains isolated in Nantes (France). Frequency of mutation to resistance.
    Courtieu AL; Drugeon H; Billaudel S
    Chemotherapy; 1977; 23 Suppl 1():25-36. PubMed ID: 401717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of fosfomycin in vitro.
    Forsgren A; Walder M
    J Antimicrob Chemother; 1983 May; 11(5):467-71. PubMed ID: 6874631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of fosfomycin and R-plasmid conferring fosfomycin resistance among some clinical bacteria isolates in Nigeria.
    Obaseiki-Ebor EE
    Chemotherapy; 1986; 32(1):31-6. PubMed ID: 3081302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of the culture medium in the sensitivity of Gram-negative stocks and their resistant mutants to fosfomycin. The influence of glucose-6-phosphate].
    Drugeon H; Courtieu AL
    Minerva Med; 1978 Dec; 69(59):4055-60. PubMed ID: 105326
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro investigations with fosfomycin on Mueller-Hinton agar with and without glucose-6-phosphate.
    Grimm H
    Infection; 1979; 7(5):256-9. PubMed ID: 389806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibacterial activities of fosfomycin against several fresh clinical isolates--comparison of the test methods for antibacterial activity].
    Hara T; Araake M; Watabe H
    Jpn J Antibiot; 2002 Dec; 55(6):844-54. PubMed ID: 12621737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the activity of the trometamol salt of fosfomycin.
    Greenwood D; Jones A; Eley A
    Eur J Clin Microbiol; 1986 Feb; 5(1):29-34. PubMed ID: 3084242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae.
    Ballestero-Téllez M; Docobo-Pérez F; Rodríguez-Martínez JM; Conejo MC; Ramos-Guelfo MS; Blázquez J; Rodríguez-Baño J; Pascual A
    Clin Microbiol Infect; 2017 May; 23(5):325-331. PubMed ID: 28062317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International collaborative study on standardization of bacterial sensitivity to fosfomycin.
    Andrews JM; Baquero F; Beltran JM; Canton E; Crokaert F; Gobernado M; Gomez-Ius R; Loza E; Navarro M; Olay T
    J Antimicrob Chemother; 1983 Oct; 12(4):357-61. PubMed ID: 6643331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medium compositions and culture conditions for the assay of fosfomycin susceptibility by Etest.
    Horii T; Kimura T; Odagiri T; Shibayama K; Ohta M
    J Infect Chemother; 2000 Mar; 6(1):30-4. PubMed ID: 11810528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of glucose-6-phosphate and inorganic phosphate on the resistance of Klebsiella species and E. coli towards fosfomycin (author's transl)].
    Hirschl A; Rotter M
    Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):461-9. PubMed ID: 396739
    [No Abstract]   [Full Text] [Related]  

  • 15. An increase in the antimicrobial activity in vitro of fosfomycin under anaerobic conditions.
    Inouye S; Watanabe T; Tsuruoka T; Kitasato I
    J Antimicrob Chemother; 1989 Nov; 24(5):657-66. PubMed ID: 2599990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of susceptibilities for fosfomycin determined by various methods in clinical isolates in 2003 -2004].
    Muramatsu H; Ishikawa J; Nagura O; Horii T
    Jpn J Antibiot; 2007 Apr; 60(2):107-24. PubMed ID: 17612258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The trometamol salt of fosfomycin: microbiological evaluation.
    Greenwood D; Coyle S; Andrew J
    Eur Urol; 1987; 13 Suppl 1():69-75. PubMed ID: 3552702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The action of fosfomycin on the growth of Pseudomonas aeruginosa.
    Hardisson C; Llaneza J
    Chemotherapy; 1977; 23 Suppl 1():37-44. PubMed ID: 401719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigations on the antibacterial activity of fosfomycin on DST-agar (author's transl)].
    Hirschl A; Rotter M; Maruna H
    Zentralbl Bakteriol Orig A; 1978 Dec; 242(4):537-46. PubMed ID: 749420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved susceptibility test based on Amberlite reveals the potential antilisterial activity of fosfomycin in vitro.
    Han L; Lei J; Han S; He L; Ma C; Yu P; Wu X; Xu J
    Can J Microbiol; 2013 Apr; 59(4):252-9. PubMed ID: 23586749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.